🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The safety and efficacy of pembrolizumab plus the investigator's choice of ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham-Medicine ( Site 0065)
Start Date
2021-06-18
Trial ID
NCT04895358
Treatments Being Tested
This study will evaluate the effect of combination therapy with verteporfin...
Status
Terminated
Location
Novartis Investigative site
Start Date
2007-05
Trial ID
NCT00433017
Treatments Being Tested
The primary objective of this study is to evaluate the safety and tolerabil...
Status
Completed
Location
Quotient Clinical
Start Date
2013-08
Trial ID
NCT01918735
This is a phase 3, multicenter, randomized, double-blind, placebo-controlle...
Status
Active Not Recruiting
Location
MorphoSys Research Site
Start Date
2021-05-11
Trial ID
NCT04824092
The purpose of this study is to assess the potential for pegloticase with m...
Status
Completed
Location
University of Alabama
Start Date
2019-06-13
Trial ID
NCT03994731
Prospective, Randomized, Double-Blind, Placebo-Controlled Phase II Trial of...
Status
Completed
Location
University of Arkansas for Medical Sciences
Start Date
2020-10-15
Trial ID
NCT04570384
Treatments Being Tested
The purpose of this clinical research study is to learn if abatacept is saf...
Status
Completed
Location
Local Institution
Start Date
2002-12
Trial ID
NCT00048932
Treatments Being Tested
This is a Phase 1, double-blind, placebo-controlled trial in three parts. A...
Status
Terminated
Location
ICON Early Phase Services Clinical Research Unit
Start Date
2019-12-04
Trial ID
NCT04117607
Treatments Being Tested
This study is a multicenter, randomized, double-blind, placebo-controlled c...
Status
Recruiting
Location
Ruijin Hospital affiliated to Shanghai Jiao Tong University
Start Date
2025-01-20
Trial ID
NCT06693362
Treatments Being Tested
This is a multicenter prospective phase IIa dose escalation and phase IIa e...
Status
Completed
Location
Indiana University School of Medicine
Start Date
2016-09-19
Trial ID
NCT02663622
Treatments Being Tested